,ATP6AP1CRC

Shijie Zhang1,2, Yan Wang1,2, Xiaodong Zhang3

  • 1Digestive Endoscopy Department, The First Affiliated Hospital with Nanjing Medical University and Jiangsu Province Hospital, Nanjing, Jiangsu, China.

Scientific reports
|February 18, 2024
PubMed
概括

在结直肠癌 (CRC) 中增加ATP6AP1表达与预后不佳和免疫细胞透的改变相关. 这表明ATP6AP1可能是一个有价值的生物标志物和CRC免疫治疗的潜在治疗标.